Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
76
DELISTED
PDL BioPharma, Inc.
PDLI
| $92.6M | 0.24% |
+11,988,554
| New | +$93.5M |
|
|
BCR
77
DELISTED
CR Bard Inc.
BCR
| $91.3M | 0.24% |
+840,500
| New | +$87.5M |
|
78
Alphabet (Google) Class C
GOOG
$4.19T
| $86.3M | 0.23% |
+3,936,620
| New | +$83.3M |
|
79
PPG Industries
PPG
$25.8B
| $86.1M | 0.23% |
+1,176,200
| New | +$87.1M |
|
80
DaVita
DVA
$11.4B
| $85.5M | 0.22% |
+1,415,900
| New | +$88.4M |
|
81
ConocoPhillips
COP
$151B
| $84.3M | 0.22% |
+1,393,713
| New | +$84.7M |
|
|
AGN
82
DELISTED
Allergan Inc
AGN
| $84.3M | 0.22% |
+1,000,660
| New | +$104M |
|
|
RAI
83
DELISTED
Reynolds American Inc
RAI
| $82.7M | 0.22% |
+3,420,800
| New | +$81M |
|
84
KLA
KLAC
$262B
| $82.1M | 0.22% |
+14,726,000
| New | +$80.4M |
|
|
LNKD
85
DELISTED
LinkedIn Corporation
LNKD
| $81.9M | 0.21% |
+459,400
| New | +$81.4M |
|
86
EOG Resources
EOG
$75.2B
| $81.5M | 0.21% |
+1,238,600
| New | +$79.4M |
|
87
Comcast
CMCSA
$91B
| $81.5M | 0.21% |
+3,902,998
| New | +$80.6M |
|
88
JPMorgan Chase
JPM
$962B
| $80.3M | 0.21% |
+1,521,886
| New | +$77.4M |
|
|
SDRL
89
DELISTED
Seadrill Limited Common Stock
SDRL
| $79.9M | 0.21% |
+7,324
| New | +$76M |
|
90
PepsiCo
PEP
$189B
| $79.7M | 0.21% |
+974,300
| New | +$79.6M |
|
91
Booking.com
BKNG
$160B
| $79.4M | 0.21% |
+2,400,000
| New | +$73.3M |
|
|
NSR
92
DELISTED
Neustar Inc
NSR
| $79.2M | 0.21% |
+1,627,300
| New | +$75.1M |
|
93
Telus
TU
$15.2B
| $78.9M | 0.21% |
+5,407,800
| New | +$93.7M |
|
94
Nike
NKE
$61.3B
| $78.3M | 0.21% |
+2,458,600
| New | +$76.5M |
|
95
Molina Healthcare
MOH
$10.2B
| $76.3M | 0.2% |
+2,051,400
| New | +$72.5M |
|
96
Ameren
AEE
$29.8B
| $76.1M | 0.2% |
+2,208,600
| New | +$77.2M |
|
97
General Mills
GIS
$20.2B
| $75.4M | 0.2% |
+1,554,500
| New | +$76.4M |
|
98
Moody's
MCO
$82.5B
| $75.3M | 0.2% |
+1,236,100
| New | +$75M |
|
99
Plains All American Pipeline
PAA
$16.3B
| $75.2M | 0.2% |
+1,346,700
| New | +$76.2M |
|
100
Maximus
MMS
$2.84B
| $75.1M | 0.2% |
+2,015,800
| New | +$77.1M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.